# VIRIDIAN THERAPEUTICS INC (VRDN)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/VRDN/

- Reporting holders: 3
- Reported value: $28.5K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $16.5K | 800 | 0.0% | 12 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $9.0K | 438 | 0.0% | 12 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $3.0K | 148 | 0.0% | 8 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $28.5K |
| Q2 2026 | 219 | $2.6B |
| Q1 2026 | 225 | $2.2B |
| Q4 2025 | 229 | $3.4B |
| Q3 2025 | 169 | $2.0B |
| Q2 2025 | 173 | $1.3B |
| Q1 2025 | 177 | $1.2B |
| Q4 2024 | 180 | $1.8B |
| Q3 2024 | 166 | $2.0B |
| Q2 2024 | 140 | $919.4M |
| Q1 2024 | 139 | $1.3B |
| Q4 2023 | 132 | $1.3B |